Laminin-R inhibitors are a class of small molecules or compounds that specifically target and interact with laminin receptors within the human body. Laminins are a family of large, complex proteins that are essential components of the extracellular matrix, a structural framework found in various tissues and organs throughout the body. Laminins play a crucial role in cell adhesion, migration, differentiation, and tissue organization. They form the foundation of the extracellular matrix and help maintain tissue integrity. Laminin receptors, also known as integrins, are cell surface proteins that bind to laminins, mediating cellular interactions with the extracellular matrix.
Laminin-R inhibitors are designed to modulate these interactions by interfering with the binding of laminin receptors to laminins. By doing so, they can potentially influence various cellular processes such as cell adhesion, migration, and signaling pathways. This class of inhibitors holds promise in research related to cell biology, tissue engineering, and the study of diseases characterized by aberrant cell-matrix interactions. Researchers are actively investigating the precise mechanisms and potential applications of laminin-R inhibitors, aiming to unlock their full potential for a deeper understanding of fundamental biological processes and their role in various health conditions.
SEE ALSO...
Items 11 to 12 of 12 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Methotrexate | 59-05-2 | sc-3507 sc-3507A | 100 mg 500 mg | $92.00 $209.00 | 33 | |
As a folate analog, Methotrexate may disrupt nucleotide synthesis, potentially impacting the expression of Laminin-R. | ||||||
Doxorubicin | 23214-92-8 | sc-280681 sc-280681A | 1 mg 5 mg | $173.00 $418.00 | 43 | |
Doxorubicin may interfere with DNA replication and repair, potentially leading to changes in Laminin-R expression. |